ICYMI: Patients with a Certain Genotype Are More Likely to Discontinue Imuran Due to Toxicity

  Dr. Cecilia Chung and associates at the Vanderbilt University’s Medical Center conducted a study published recently in MedPage Today. Results showed that patients who had inflammatory disorders, as well…

Continue Reading ICYMI: Patients with a Certain Genotype Are More Likely to Discontinue Imuran Due to Toxicity
Jyseleca for Ulcerative Colitis Approved in Scotland for NHS Coverage
Source: https://unsplash.com/photos/ZHys6xN7sUE

Jyseleca for Ulcerative Colitis Approved in Scotland for NHS Coverage

  What happens when you treat your condition, but the medication isn’t effective? Sometimes, other approved medications are beneficial for patient use, but other times, there are no approved medications.…

Continue Reading Jyseleca for Ulcerative Colitis Approved in Scotland for NHS Coverage
Phase 2 PRA023 Trial for UC Begins
source: pixabay.com

Phase 2 PRA023 Trial for UC Begins

Clinical trials are important research tools to help understand the safety, efficacy, and tolerability of potential treatments. According to a news release from July 19, 2021, biotechnology company Prometheus Biosciences,…

Continue Reading Phase 2 PRA023 Trial for UC Begins
SHR0302 for UC Met Trial Endpoints
stevepb / Pixabay

SHR0302 for UC Met Trial Endpoints

  Since its inception, biopharmaceutical company Reistone Biopharma Co. Ltd. ("Reistone") has worked to develop treatment options for patients with immuno-inflammatory and autoimmune conditions. Most recently, their drug candidate SHR0302,…

Continue Reading SHR0302 for UC Met Trial Endpoints
People with IBD are Concerned Their Medication Raises Their Risk of Coronavirus
source: pixabay.com

People with IBD are Concerned Their Medication Raises Their Risk of Coronavirus

As reported in EMJ Reviews, the world is on alert, being told to wash their hands and keep distance amidst the COVID-19 pandemic. However, patients with inflammatory bowel disease (IBD)…

Continue Reading People with IBD are Concerned Their Medication Raises Their Risk of Coronavirus
Deep Learning Platform Ultivision Can Predict Ulcerative Colitis Severity
[Source: pixabay.com]

Deep Learning Platform Ultivision Can Predict Ulcerative Colitis Severity

Recently, Docbot, Inc. ("Docbot") announced results from a study performed on Ultivision. Altogether, Docbot's mission has been to create artificial intelligence (AI) technologies that can be applied within a healthcare…

Continue Reading Deep Learning Platform Ultivision Can Predict Ulcerative Colitis Severity
Zeposia as a Treatment for Ulcerative Colitis Shows Positive Results in Phase 3 Trial
source: pixabay.com

Zeposia as a Treatment for Ulcerative Colitis Shows Positive Results in Phase 3 Trial

According to a story from Pharma Advancement, Bristol Myers Squibb recently announced encouraging findings from a phase 3 clinical trial. This study was testing its drug ozanimod (marketed as Zeposia)…

Continue Reading Zeposia as a Treatment for Ulcerative Colitis Shows Positive Results in Phase 3 Trial
Oral Treatment for Inflammatory Bowel Disease Doses First Patients in Phase 1 Trial
source: pixabay.com

Oral Treatment for Inflammatory Bowel Disease Doses First Patients in Phase 1 Trial

As reported in BioSpace; trials for an oral treatment to treat inflammatory bowel disease (IBD) by Morphic Therapeutics has just dosed their first healthy subjects in the Phase 1 trial.…

Continue Reading Oral Treatment for Inflammatory Bowel Disease Doses First Patients in Phase 1 Trial

IVX Health Opens 3 Tampa-Based Infusion Centers to Treat MS and Other Chronic Conditions

Recently, IVX Health announced the opening of three new Tampa-based infusion centers to treat patients with chronic conditions. Currently, IVX Health, who describes themselves as "[providing] biologic injections and infusions…

Continue Reading IVX Health Opens 3 Tampa-Based Infusion Centers to Treat MS and Other Chronic Conditions
Inflammatory Bowel Disease: Chronic Inflammation Can Cause Divergent Evolution in Colon Cells
source: pixabay.com

Inflammatory Bowel Disease: Chronic Inflammation Can Cause Divergent Evolution in Colon Cells

by Danielle Bradshaw from In The Cloud Copy Healthy and diseased colon cells were collected and compared to each other in a recent study to discover why inflammatory bowel disease…

Continue Reading Inflammatory Bowel Disease: Chronic Inflammation Can Cause Divergent Evolution in Colon Cells

A Subcutaneous Form of Remsima May be Available Soon in the EU

Celltrion Healthcare has just announced positive progress for extending the authorization for the subcutaneous (SC) form of Remsima to five more autoimmune conditions. These are- Psoriatic arthritis Ankylosing spondylitis (AS)…

Continue Reading A Subcutaneous Form of Remsima May be Available Soon in the EU
AGA Recommendations: No Probiotics for Patients with Ulcerative Colitis and Other Digestive Disorders
Sourced from Daily Nouri on Unsplash

AGA Recommendations: No Probiotics for Patients with Ulcerative Colitis and Other Digestive Disorders

  Over the last few years, I've heard the refrain that my health - oddly - starts in my gut. So whenever I got sick, someone would advise me to…

Continue Reading AGA Recommendations: No Probiotics for Patients with Ulcerative Colitis and Other Digestive Disorders